You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Afrezza

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous

Recruiting
  • Type 1 Diabetes
  • Afrezza (insulin human) Inhalation Powder
  • +2 more
  • Loma Linda, California
  • +1 more
Apr 12, 2022

Diabetes, Type 1, Diabetes, Type 2 Trial in Escondido, Walnut Creek (Afrezza Dose 1, Afrezza Dose 2)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Afrezza Dose 1
  • Afrezza Dose 2
  • Escondido, California
  • +1 more
Jun 11, 2021

Type 1 Diabetes Trial in United States (Afrezza)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Afrezza
  • Los Angeles, California
  • +12 more
Mar 11, 2021

Type2 Diabetes Trial in Baltimore (Afrezza Inhalant Product)

Completed
  • Type2 Diabetes
  • Afrezza Inhalant Product
  • Baltimore, Maryland
    MODEL Clinical Research
Sep 14, 2020

Type 2 Diabetes Treated With Insulin Trial in San Antonio (Afrezza Inhalant Product)

Unknown status
  • Type 2 Diabetes Treated With Insulin
  • Afrezza Inhalant Product
  • San Antonio, Texas
    Diabetes and Glandular Disease Clinic, P.A.
Jan 28, 2020

Diabetes, Type 1 Trial in Aurora (Technosphere insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Technosphere insulin
  • Aurora, Colorado
    Barbara Davis Center
Jan 28, 2022

Diabetes, Type 2 Trial in New York (Afrezza plus One Drop | Premium, One Drop | Premium)

Unknown status
  • Diabetes Mellitus, Type 2
  • Afrezza plus One Drop | Premium
  • One Drop | Premium
  • New York, New York
    One Drop
Feb 25, 2019

Type 1 Diabetes Trial in Neuss (SAR439065, Insulin lispro)

Completed
  • Type 1 Diabetes Mellitus
  • Neuss, Germany
    Investigational Site Number 276001
Apr 12, 2017

Type 1 Diabetes Trial in Mainz (Technosphere Insulin SAR439065 Afrezza®)

Completed
  • Type 1 Diabetes Mellitus
  • Technosphere Insulin SAR439065 Afrezza®
  • Mainz, Germany
    Investigational Site Number 276001
Mar 13, 2017

Type 1 Diabetes, Type 2 Diabetes, Moderate COPD Trial in Russian Federation, Ukraine, United States (Technosphere® Insulin,

Terminated
Has Results
  • Type 1 Diabetes Mellitus
  • +3 more
  • Technosphere® Insulin
  • Usual Care
  • Mission Hills, California
  • +20 more
Apr 12, 2017

Type 1 Diabetes, Type 2 Diabetes Trial in United States (Technosphere Insulin Inhalation Powder)

No longer available
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Technosphere Insulin Inhalation Powder
  • Montgomery, Alabama
  • +13 more
Jan 19, 2016